The world is bracing for a new wave of Covid-19 infections, as the coronavirus pandemic has infected more than 113 million people and killed more than 2.5 million globally since late January 2020.
Efforts many countries took to stamp out the pneumonia-like illness led to entire nations enforcing lockdowns, widespread halts of international travel, mass layoffs and battered financial markets.
Recent attempts to revive social life and financial activities have resulted in another surge in cases and hospitalizations, though new drugs and improved care may help more people who get seriously ill survive.
This is not another vaccine, we are looking into developing a “neutralizing antidote” and “convalescent plasma” using the Beta-Thalassemia Gene Mutation and O RH Negative Blood Combination found in our blood.
We have a genetic mutation on our chromosome 11 called beta-thalassemia that makes us immune to Malaria, Dengue Virus and Covid-19. We are getting tested to confirm that we also have the LRP5V171 “unbreakable bones” mutation and the ACTN3 “speed gene” mutation which are also found on chromosome 11.
Furthermore we are O RH Negative. We are universal donors and can safely give blood to trauma patients, premature babies, cancer patients and everyone reading this.
Our unique blood combination can be used to create this convalescent plasma and monoclonal antibodies to treat Covid-19 in infected patients. But we can only donate blood every 2 months, we need to somehow create more of this therapeutic plasma to add to the arsenal in this battle against Covid-19.
According to scientists and the National Center for Biotechnology Information..
“The hypothesis we posit is that thalassemia traits in general, and particularly HbE, are protective against COVID-19 infection in similar ways to the numerous thalassemia traits conferring protection against malaria and the dengue virus.
Intriguing epidemiological observations suggest, and biological evidence supports, an inverse correlation between increasing HbE/thalassemia trait prevalence rates and decreased susceptibility to, and fatality from, COVID-19 infections
There are so many wonders that can be uncovered through science particularly in such an area that has elicited discussion within the medical field regarding how exactly this blood mutation works. I believe by doing something about it by way of this campaign, I will contribute and further hasten progress at a time when creative solutions are needed to help curb the spread of the coronavirus.
Furthermore, we will undergo tests to help determine whether it is possible to clone our antibodies to give others passive immunity while also testing our plasma and stem cells. Even if 2 transfusions were achievable every 56 days between the 2 of us we could save 13 lives a year! We have launched this Go Fund Me campaign to help support this goal – we appreciate any contribution you can make if you are able to, thank you and stay safe!
To find out more, please visit the following sites:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217120/
https://www.sciencedirect.com/science/article/abs/pii/S0306987720308124
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796072/